RespireRx Pharmaceuticals Inc. Files June 30, 2016 Quarterly Report on Form 10-Q
GLEN ROCK, NJ -- (Marketwired) -- 08/15/16 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the development of medicines for respiratory disorders, including sleep apneas and drug-induced …